These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36224002)

  • 1. The Role of Epigenetic Regulator SIRT1 in Balancing the Homeostasis and Preventing the Formation of Specific "Soil" of Metabolic Disorders and Related Cancers.
    Nemeth Z; Kiss E; Takacs I
    Front Biosci (Landmark Ed); 2022 Aug; 27(9):253. PubMed ID: 36224002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interplay of Vitamin D and SIRT1 in Tissue-Specific Metabolism-Potential Roles in Prevention and Treatment of Non-Communicable Diseases Including Cancer.
    Nemeth Z; Patonai A; Simon-Szabó L; Takács I
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of SIRT1 on DNA Damage Response and Epigenetic Alterations in Cancer.
    Alves-Fernandes DK; Jasiulionis MG
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders.
    Kauppinen A; Suuronen T; Ojala J; Kaarniranta K; Salminen A
    Cell Signal; 2013 Oct; 25(10):1939-48. PubMed ID: 23770291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketone Bodies and SIRT1, Synergic Epigenetic Regulators for Metabolic Health: A Narrative Review.
    Tozzi R; Cipriani F; Masi D; Basciani S; Watanabe M; Lubrano C; Gnessi L; Mariani S
    Nutrients; 2022 Jul; 14(15):. PubMed ID: 35956321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progression of deacetylase (SIRT1)].
    Chen HZ; Zhang ZQ; Wei YS; Liu DP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Jun; 29(3):441-7. PubMed ID: 17633479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism.
    Nogueiras R; Habegger KM; Chaudhary N; Finan B; Banks AS; Dietrich MO; Horvath TL; Sinclair DA; Pfluger PT; Tschöp MH
    Physiol Rev; 2012 Jul; 92(3):1479-514. PubMed ID: 22811431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT1 - an anti-inflammatory pathway at the crossroads between metabolic disease and atherosclerosis.
    Winnik S; Stein S; Matter CM
    Curr Vasc Pharmacol; 2012 Nov; 10(6):693-6. PubMed ID: 23259556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirtuin 1: A Target for Kidney Diseases.
    Kong L; Wu H; Zhou W; Luo M; Tan Y; Miao L; Cai L
    Mol Med; 2015 Jan; 21(1):87-97. PubMed ID: 25587857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARα and Sirt1 mediate erythropoietin action in increasing metabolic activity and browning of white adipocytes to protect against obesity and metabolic disorders.
    Wang L; Teng R; Di L; Rogers H; Wu H; Kopp JB; Noguchi CT
    Diabetes; 2013 Dec; 62(12):4122-31. PubMed ID: 23990359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature or nurture: let food be your epigenetic medicine in chronic inflammatory disorders.
    Szarc vel Szic K; Ndlovu MN; Haegeman G; Vanden Berghe W
    Biochem Pharmacol; 2010 Dec; 80(12):1816-32. PubMed ID: 20688047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-aging molecule, Sirt1: a novel therapeutic target for diabetic nephropathy.
    Kume S; Kitada M; Kanasaki K; Maegawa H; Koya D
    Arch Pharm Res; 2013 Feb; 36(2):230-6. PubMed ID: 23361587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirtuin 1 deacetylase: a key regulator of hepatic lipid metabolism.
    Kemper JK; Choi SE; Kim DH
    Vitam Horm; 2013; 91():385-404. PubMed ID: 23374725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoterpenes as Sirtuin-1 Activators: Therapeutic Potential in Aging and Related Diseases.
    Sousa C; Mendes AF
    Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRT1 and SIRT2: emerging targets in neurodegeneration.
    Donmez G; Outeiro TF
    EMBO Mol Med; 2013 Mar; 5(3):344-52. PubMed ID: 23417962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol-activated SIRT1 in liver and pancreatic β-cells: a Janus head looking to the same direction of metabolic homeostasis.
    Vetterli L; Maechler P
    Aging (Albany NY); 2011 Apr; 3(4):444-9. PubMed ID: 21483037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The anti-aging, metabolism potential of SIRT1.
    Ghosh HS
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1095-102. PubMed ID: 18821472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parental SIRT1 Overexpression Attenuate Metabolic Disorders Due to Maternal High-Fat Feeding.
    Nguyen LT; Saad S; Chen H; Pollock CA
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic effects of natural polyphenols: a focus on SIRT1-mediated mechanisms.
    Ayissi VB; Ebrahimi A; Schluesenner H
    Mol Nutr Food Res; 2014 Jan; 58(1):22-32. PubMed ID: 23881751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.